Show simple item record

dc.contributor.authorGaiti, F.
dc.contributor.authorHawkins, A.
dc.contributor.authorChamely, P.
dc.contributor.authorSwett, A.
dc.contributor.authorDai, X.
dc.contributor.authorKluegel, L.
dc.contributor.authorChen, C.
dc.contributor.authorBeaulaurier, J.
dc.contributor.authorDrong, A.
dc.contributor.authorHickey, S.
dc.contributor.authorMouhieddine, T. H.
dc.contributor.authorIzzo, F.
dc.contributor.authorDusaj, N.
dc.contributor.authorChaligne, R.
dc.contributor.authorJuul, S.
dc.contributor.authorWiseman, Daniel H
dc.contributor.authorHarrington, E.
dc.contributor.authorTaylor, J.
dc.contributor.authorGhobrial, I. M.
dc.contributor.authorAbdel-Wahab, O.
dc.contributor.authorLandau, D. A.
dc.date.accessioned2022-10-19T13:13:16Z
dc.date.available2022-10-19T13:13:16Z
dc.date.issued2021en
dc.identifier.citationGaiti F, Hawkins A, Chamely P, Swett A, Dai X, Kluegel L, et al. Single-Cell Multi-Omics Defines the Cell-Type Specific Impact of SF3B1 Splicing Factor Mutations on Hematopoietic Differentiation in Human Clonal Hematopoiesis and Myelodysplastic Syndromes. Blood. 2021 Nov;138. PubMed PMID: WOS:000736398800143.en
dc.identifier.doi10.1182/blood-2021-147529en
dc.identifier.urihttp://hdl.handle.net/10541/625628
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1182/blood-2021-147529en
dc.titleSingle-cell multi-omics defines the cell-type specific impact of SF3B1 splicing factor mutations on hematopoietic differentiation in human clonal hematopoiesis and myelodysplastic syndromesen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMeyer Cancer Center & Institute of Computational Biomedicine, Weill Cornell Medicine, New York, NYen
dc.identifier.journalBlooden
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record